ANDAORAL, RECTALPOWDER
Approved
Jan 1989
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
SODIUM POLYSTYRENE SULFONATE (sodium polystyrene sulfonate) by CMP Pharma is potassium ion exchange activity [moa]. First approved in 1989.
Drug data last refreshed 19h ago
Mechanism of Action
Potassium Ion Exchange Activity
Pharmacologic Class:
Potassium Binder
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
CMP Pharma
NC - Farmville
Worked on SODIUM POLYSTYRENE SULFONATE at CMP Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.